Skip to main content

Table.2 Antibiotics on admission and during hospitalization (n = 232,396)

From: Hospitalization for urinary tract infections in Japan, 2010–2015: a retrospective study using a national inpatient database

  1st day (%) During hospitalization (%)
Penicillins 21.6 30.7
First generation cephalosporins 5.1 11.5
Second generation cephalosporins 18.5 24.0
Third generation cephalosporins 37.9 51.5
Fourth generation cephalosporins 4.4 6.1
Carbapenems 10.7 18.7
 Category of broadness of beta-lactams
  Carbapenems 10.7 18.7
  Antipseudomonal beta-lactams 23.8 30.2
  Third generation cephalosporins without antipseudomonal activity 31.8 45.0
  Penicillins with beta-lactamase inhibitor 7.9 11.5
  Other beta-lactams 24.1 37.2
Anti-MRSA drugs 0.9 3.3
Aminoglycosides 1.6 3.3
Fluoroquinolones 4.5 30.2
  1. MRSA methicillin-resistant Staphylococcus aureus